Fairbanks Foundation gives $20M to IUPUI public health school
The Indianapolis-based Richard M. Fairbanks Foundation is contributing $20 million to support IUPUI’s effort to open
a school of public health.
The Indianapolis-based Richard M. Fairbanks Foundation is contributing $20 million to support IUPUI’s effort to open
a school of public health.
One in five medical claims is processed inaccurately by commercial health insurers—and a unit of Indianapolis-based
WellPoint Inc. does even worse—often leaving physicians shortchanged, according to the nation's largest doctor's
group.
Thompson Thrift, based in Terre Haute and Carmel, has started construction on Washington Square Commons, a 9,000-square-foot
retail strip at 10110 E. Washington St., at a major entrance to Washington Square Mall.
Company announced plans in May 2009 for a $2 million lube shop and car wash in Avon. But more than a year later, work hasn’t
started.
Addition of University of Nebraska to conference in 2011 will lead to football playoff.
Pat Bauer sent Indiana Secretary of Commerce Mitch Roob a letter formally requesting the Indiana Economic Development Corp.
disclose public records about promises companies gave the state in exchange for job-creation incentives.
Three of the four principals in Page Development were in court June 8 to sift through the fallout from a $1.35 million judgment
against them. It’s only the tip of Page Development’s financial straits.
A fixture in downtown Indianapolis since 1987, the Academy hasn’t yet been evicted from its Pan American Plaza ice rinks,
but it operates under a cloud of uncertainty.
India-based JPSK Sports Private Ltd. hired JMI to provide strategic consulting for the venue that will host the inaugural
Formula One Indian Grand Prix in 2011.
The state is building a massive data system with a tough-love intent of rewarding good educators and schools and hammering
poor performers.
News from the Center for the Performing Arts…and some of its soon-to-be resident companies.
IUPUI took two steps closer to creating a School of Public Health as it gave Lilly Scholars awards to help
two professors start up public health research projects. The awards are funded by a $1 million gift from the Eli Lilly
and Co. Foundation. Jennifer Wessel, who was hired from personalized genetics company SRI International, will focus
her research on developing interventions based on individuals' genetic profiles that can promote healthy lifestyles to
prevent or delay coronary artery disease. Silvia M. Bigatti, who has been a professor of psychology at the Indiana
University School of Medicine since 2000, will study factors related to stress and coping in cancer patients and
their partners and also community-based preventive health behaviors among Latinos.
The Indiana Bureau of Motor Vehicles has approved a Stop Diabetes specialty license plate. Like Indiana's
other special group-recognition license plates, the Stop Diabetes plate will cost $40, with $25 of that cost directly benefiting
the American Diabetes Association. The funds raised will support education and research about diabetes. According to the American
Diabets Association, more than 714,000 Hoosiers have diabetes and at least 1.6 million, roughly a fourth of the state's
population, are at high risk for it.
Endocyte Inc.'s experimental cancer drug doubled survival times for women with difficult cases of ovarian
cancer. In a clinical trial of 91 women, Endocyte’s drug EC145, when combined with another chemotherapy drug, Doxil,
held off ovarian cancer for six months, compared with 3 months for patients given Doxil alone. The data are interim results
from a Phase 2 clinical trial involving 150 women. Endocyte, based in West Lafayette, plans to move its drug into a large
Phase 3 trial later this year.
Indianapolis-based Eli Lilly and Co. and Merck KGaA’s Erbitux failed to slow early-stage colon cancer,
in a clinical trial that left scientists mystified. Erbitux is already approved to treat colon cancer in advanced stages,
and scientists presumed it would also work in earlier stages, according to Bloomberg News. The finding is the latest of at
least three studies that have narrowed the scope of Erbitux. It recorded sales last year of $1.4 billion, according to IMS
Health.
Indianapolis developer Buckingham Cos. is in discussions to build a mixed-use development that could include apartments, shops,
office space, and a hotel and conference center.
WellPoint may face the most threat from more aggressive reviews. The Indianapolis insurer is the leader in small-business
and individual policies, areas that have seen the biggest increases in recent years.
A lawyer says too many parents withhold information about estate from heirs and unwittingly set up the heirs for a battle.
Jim Irsay and Herb Simon join to co-chair fund-raising committee for the Indianapolis Symphony Orchestra, which has encountered
financial troubles the past few years.
The Indianapolis-based insurer’s first-quarter spending is 16 percent more than it spent in the same quarter last year and
in the fourth quarter of 2009.
IBJ investigation prompts top state Democrat's letter to U.S. Department of Health and Human Services.
Charities and not-for-profits are trying to broaden their appeal to younger adults without turning off older stalwarts.